Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday. The company traded as high as $28.6899 and last traded at $28.6899, with a volume of 4909 shares traded. The stock had previously closed at $27.67.
Wall Street Analyst Weigh In
Separately, Zacks Research downgraded WuXi AppTec from a “strong-buy” rating to a “hold” rating in a research note on Monday. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Analysis on WuXi AppTec
WuXi AppTec Price Performance
About WuXi AppTec
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
Recommended Stories
- Five stocks we like better than WuXi AppTec
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
- Morgan Stanley Is Bullish on Apple—But With a Catch
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
